Increased activity of USP14, a proteasome-associated DUB, was observed in melanoma cells and in melanoma patients compared to normal skin and nevi b-AP15, a selective USP14 inhibitor; the USP14 reduced proliferation of melanoma cells independent of the mutational cell status. Here, USP14 is linked to melanoma.